Evidence map›Paper›PMID 40705657›Full record

ArticleBioanalysis2025

Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS).

Ethan J Sanford, Jianzhong Chen, Julia Tran, Ilia Korboukh, Guangnong Zhang

Abstract read
In one paragraph

Article in Bioanalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ethan J SanfordDicerna Pharmaceuticals, A Novo Nordisk Company, Lexington, MA, USA.ORCID 0000-0003-0722-3058
Jianzhong ChenDicerna Pharmaceuticals, A Novo Nordisk Company, Lexington, MA, USA.
Julia TranDicerna Pharmaceuticals, A Novo Nordisk Company, Lexington, MA, USA.
Ilia KorboukhDicerna Pharmaceuticals, A Novo Nordisk Company, Lexington, MA, USA.
Guangnong ZhangDicerna Pharmaceuticals, A Novo Nordisk Company, Lexington, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOligonucleotide therapeutics (ONTs) are a rapidly growing class of drug, with 20+ approved drugs on the market and more undergoing preclinical and clinical investigation for various indications. Many groups in the field are appending chemical modifications to modulate tissue specificity. Conjugation of long-chain fatty acids to siRNA molecules increases the hydrophobicity of the analyte and poses analytical challenges for extraction and LC-MS.

resultsWe report the development and optimization of an SPE extraction method for a lipid-conjugated siRNA. To improve assay quantitation by LC-MS, a stable isotope label internal standard (SILIS) was evaluated that enabled robust quantitation with high accuracy and precision (±5% in most cases).

conclusionWe demonstrate the performance of the assay in mouse plasma and tissue homogenates and apply the assay to the determination of tissue exposure and plasma PK profile for a novel lipid-conjugated siRNA molecule and suggest that a SILIS quantitation approach should be standard practice in siRNA bioanalysis.

Indexed as

LipidsRNA, Small InterferingSolid Phase ExtractionTandem Mass SpectrometryAnimalsChromatography, LiquidIsotope LabelingLiquid Chromatography-Mass SpectrometryMiceReference StandardsLipidsRNA, Small InterferingBioanalysisLC-MS/MSmethod developmentoligonucleotideSILISsiRNAsolid phase extractionstable isotope label

Identifiers

PMID40705657
PMCPMC12369610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.